Merve Karpuz

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Rheumatoid Arthritis

Pseudomonas Aeruginosa

Silver Nanoparticles

Top Venues

AAPS PharmSciTech

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Merve Karpuz, Husniye Hande Aydin, Emre Ozgenc, Gulsah Erel-Akbaba, Evren Atlihan-Gundogdu, Zeynep Senyigit
99m Tc-labeled, tofacitinib citrate encapsulated chitosan microspheres loaded in situ gel formulations for intra-articular treatment of rheumatoid arthritis. Drug development research 85 (5) (2024)
Merve Karpuz, Aybala Temel, Emre Ozgenc, Yamac Tekintas, Gulsah Erel-Akbaba, Zeynep Senyigit, Evren Atlihan-Gundogdu
99m Tc-Labeled, Colistin Encapsulated, Theranostic Liposomes for Pseudomonas aeruginosa Infection. AAPS PharmSciTech 24 (3) (2023)
Merve Karpuz, Aybala Temel, Emre Ozgenc, Yamac Tekintas, Gulsah Erel-Akbaba, Zeynep Senyigit, Evren Atlihan-Gundogdu
99m Tc-Labeled, Colistin Encapsulated, Theranostic Liposomes for Pseudomonas aeruginosa Infection. AAPS PharmSciTech 24 (3) (2023)
Merve Karpuz, Emre Ozgenc, Ezgi Oner, Evren Atlihan-Gundogdu, Zeynep Burak
68 Ga-labeled, imatinib encapsulated, theranostic liposomes: Formulation, characterization, and in vitro evaluation of anticancer activity. Drug development research (2023)
Merve Karpuz, Aybala Temel, Emre Ozgenc, Yamac Tekintas, Gulsah Erel-Akbaba, Zeynep Senyigit, Evren Atlihan-Gundogdu
99m Tc-Labeled, Colistin Encapsulated, Theranostic Liposomes for Pseudomonas aeruginosa Infection. AAPS PharmSciTech 24 (3) (2023)